News by Subject
List and find news items by the subject covered
Subject A-Z
To view a list of news subjects currently covered, please select a subject initial letter from the line below.
News items on 'Prostate Specific Antigen'
Prostate screening under scrutiny
(BBC 25/09/2009)
Routine screening for prostate cancer has come under further scrutiny after two studies concluded it may do more harm than good. European researchers found the current prostate specific antigen (PSA) test cannot reliably rule out a future diagnosis of prostate cancer. Another article, also in the British Medical Journal, found the long-term benefits of screening were unclear. Although there is no formal screening in the UK, PSA testing is on the rise.
Men face 'two-tier system' in access to cancer test
(The Scotsman 28/07/2009)
The prostate-specific antigen (PSA) test can help in the diagnosis of the cancer, which affects more men in the UK than any other. Each year, nearly 35,000 men are diagnosed and more than 10,000 die from the disease. But the Prostate Cancer Charity have claimed that men have to overcome opposition from doctors to gain access to this test. A survey of GPs carried out by the charity revealed 20 per cent of those questioned disagreed that men should have access to the test at all.
GPs under fire over prostate cancer test that 'could save 100 lives a year'
(The Scotsman 07/06/2009)
MEN in Glasgow are up to four times more likely to die of prostate cancer than in other parts of the UK because GPs are failing to detect the disease early, a leading surgeon has warned. Up to 100 deaths could be avoided every year in the west of Scotland if men were given routine tests for the disease, according to Professor Hing Leung, a consultant urological surgeon from the Beatson Institute for Cancer Research in Glasgow.
Prostate cancer screening for men 'should be introduced to UK'
(Telegraph 18/03/2009)
A major European study found that death rates from prostate cancer could be reduced by around 20 per cent by national screening. If deaths from prostate cancer in the UK were cut by 20 per cent around 2,000 lives would be saved each year. The Prostate Cancer Charity said the current policy not to fund NHS prostate cancer screening should now be revisited.
Prostate screening to be reviewed
(BBC 18/03/2009)
Routine prostate cancer screening could cut death rates from the disease by 20%, a major study suggests. The results, which suggest 2,000 lives a year could be saved in the UK, have prompted a review of the current policy not to offer routine NHS screening. The study, based on results from 162,000 men, assessed the impact of testing levels of a protein called prostate specific antigen (PSA).
Read background >>
Read NHS analysis >>
Comment on this story >>
Test that will spot prostate danger in ten minutes
(Daily Mail 06/10/2008)
A new test, called PSAWatch, makes it easier to screen men for prostate cancer - potentially saving thousands of lives. It needs only a small drop of blood from a finger-prick which is analysed using a portable machine. Conventional tests require blood to be sent to a laboratory. The test, costing around £40, is being made available throughout the UK. It is not yet available on the NHS.
Advert
Advert
Advert
| Top 10 Drug Information Leaflets | |
|---|---|
| Co-codamol | |
| Citalopram | |
| Prednisolone | |
| Omeprazole | |
| Metronidazole | |
| Diclofenac | |
| Ramipril | |
| Simvastatin | |
| Flucloxacillin | |
| Mebeverine hydrochloride | |